Skip to main content
PMC home page
Gut logoLink to Gut
. 1986 Dec;27(12):1484–1492. doi: 10.1136/gut.27.12.1484

Synthesis of prostaglandin E2, thromboxane B2 and prostaglandin catabolism in gastritis and gastric ulcer.

C J Hawkey
PMCID: PMC1433969  PMID: 3468053

Abstract

Because endogenous prostaglandins may protect the gastric mucosa a study was conducted to determine factors influencing the synthesis of immunoreactive prostaglandin (iPG) E2 and thromboxane (iTx) B2 as measured by radioimmunoassay and prostaglandin catabolism measured radiometrically, in human gastric mucosa. Gastric mucosa was obtained at endoscopy. Synthesis of iPE2 and iTxB2 was inhibited in vitro by indomethacin; iTxB2 synthesis was also selectively inhibited by the thromboxane synthesis inhibitor dazmegrel. Prostaglandin catabolism was inhibited by carbenoxolone. Multivariate analysis showed that synthesis of iPGE2 from endogenous precursor during homogenisation was decreased in patients on non-steroidal anti-inflammatory drugs. Mucosal inflammation was associated with significantly increased synthesis of iPGE2 and decreased prostaglandin catabolism. There were no differences between the mucosa of patients with or without gastric ulcers, nor between the ulcer rim and mucosa 5 cm away. Age, sex, smoking history and ingestion of antisecretory drugs appeared to exert no influence. In this study gastritis was the major influence on prostaglandin synthesis. It seems unlikely that prostaglandin deficiency is a strong predisposing factor for gastric ulceration.

Full text

PDF
1487

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Branski D., Sharon P., Karmeli F., Rachmilewitz D. Effect of cimetidine on human gastric and duodenal prostanoid synthesis. Scand J Gastroenterol. 1984 Jun;19(4):457–460. [PubMed] [Google Scholar]
  2. Coggon D., Lambert P., Langman M. J. 20 years of hospital admissions for peptic ulcer in England and Wales. Lancet. 1981 Jun 13;1(8233):1302–1304. doi: 10.1016/s0140-6736(81)92470-3. [DOI] [PubMed] [Google Scholar]
  3. Hawkey C. J., Lo Casto M. Inhibition of prostaglandin synthetase in human rectal mucosa. Gut. 1983 Mar;24(3):213–217. doi: 10.1136/gut.24.3.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hawkey C. J., Rampton D. S. Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? Gastroenterology. 1985 Nov;89(5):1162–1188. doi: 10.1016/0016-5085(85)90225-2. [DOI] [PubMed] [Google Scholar]
  5. Hawkey C. J., Truelove S. C. Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay. Gut. 1981 Mar;22(3):190–193. doi: 10.1136/gut.22.3.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Konturek S. J., Brzozowski T., Piastucki I., Radecki T., Dembińska-Kieć A. Role of prostaglandin and thromboxane biosynthesis in gastric necrosis produced by taurocholate and ethanol. Dig Dis Sci. 1983 Feb;28(2):154–160. doi: 10.1007/BF01315145. [DOI] [PubMed] [Google Scholar]
  7. Konturek S. J., Brzozowski T., Piastucki I., Radecki T., Dembiński A., Dembińska-Kieć A. Role of locally generated prostaglandins in adaptive gastric cytoprotection. Dig Dis Sci. 1982 Nov;27(11):967–971. doi: 10.1007/BF01391740. [DOI] [PubMed] [Google Scholar]
  8. Peskar B. M., Holland A., Peskar B. A. Effect of carbenoxolone on prostaglandin synthesis and degradation. J Pharm Pharmacol. 1976 Feb;28(2):146–148. doi: 10.1111/j.2042-7158.1976.tb04113.x. [DOI] [PubMed] [Google Scholar]
  9. Peskar B. M., Seyberth H. W., Peskar B. A. Synthesis and metabolism of endogenous prostaglandins by human gastric mucosa. Adv Prostaglandin Thromboxane Res. 1980;8:1511–1514. [PubMed] [Google Scholar]
  10. Rampton D. S., Hawkey C. J. Prostaglandins and ulcerative colitis. Gut. 1984 Dec;25(12):1399–1413. doi: 10.1136/gut.25.12.1399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Robert A., Nezamis J. E., Lancaster C., Davis J. P., Field S. O., Hanchar A. J. Mild irritants prevent gastric necrosis through "adaptive cytoprotection" mediated by prostaglandins. Am J Physiol. 1983 Jul;245(1):G113–G121. doi: 10.1152/ajpgi.1983.245.1.G113. [DOI] [PubMed] [Google Scholar]
  12. Schlegel W., Wenk K., Dollinger H. C., Raptis S. Concentrations of prostaglandin A-, E- and F-like substances in gastric mucosa of normal subjects and of patients with various gastric diseases. Clin Sci Mol Med. 1977 Mar;52(3):255–258. doi: 10.1042/cs0520255. [DOI] [PubMed] [Google Scholar]
  13. Walt R., Katschinski B., Logan R., Ashley J., Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet. 1986 Mar 1;1(8479):489–492. doi: 10.1016/s0140-6736(86)92940-5. [DOI] [PubMed] [Google Scholar]
  14. Whitehead R., Truelove S. C., Gear M. W. The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol. 1972 Jan;25(1):1–11. doi: 10.1136/jcp.25.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Whittle B. J., Kauffman G. L., Moncada S. Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa. Nature. 1981 Jul 30;292(5822):472–474. doi: 10.1038/292472a0. [DOI] [PubMed] [Google Scholar]
  16. Wright J. P., Young G. O., Klaff L. J., Weers L. A., Price S. K., Marks I. N. Gastric mucosal prostaglandin E levels in patients with gastric ulcer disease and carcinoma. Gastroenterology. 1982 Feb;82(2):263–267. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES